Clinical Trials for IGF1 Deficiency

Global Patient Registry to Monitor Long-term Safety and Effectiveness of Increlex® in Children and Adolescents With Severe Primary Insulin-like Growth Factor-1 Deficiency (SPIGFD).

NCT ID: NCT00903110

The Global Patient Registry is a study designed to monitor the long-term safety and effectiveness of a medication called Increlex® in children and teenagers who have a condition known as severe pri...